DC Field | Value | Language |
---|---|---|
dc.contributor.author | M Y Lee | - |
dc.contributor.author | B Y Park | - |
dc.contributor.author | Ok-Kyoung Kwon | - |
dc.contributor.author | Ji Eun Yuk | - |
dc.contributor.author | Sei Ryang Oh | - |
dc.contributor.author | Hui-Seong Kim | - |
dc.contributor.author | Hyeong Kyu Lee | - |
dc.contributor.author | Kyung Seop Ahn | - |
dc.date.accessioned | 2017-04-19T09:13:53Z | - |
dc.date.available | 2017-04-19T09:13:53Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1567-5769 | - |
dc.identifier.uri | 10.1016/j.intimp.2009.03.012 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/8984 | - |
dc.description.abstract | In the present study, we investigated that (-)-aptosimon, isolated from flower buds of Daphne genkwa, inhibited cyclooxygenase-2 (COX-2) and inducible nitric oxide (NO) synthase (iNOS) expression in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Similarly, (-)-aptosimon suppressed tumor necrosis factor (TNF)-α production. Our results clearly indicated that (-)-aptosimon inhibited LPS-induced nuclear factor-κB (NF-κB) activation, by preventing degradation of the inhibitor kappa B-alpha (IκB-α). (-)-Aptosimon also inhibited interleukin-4 (IL-4) and interleukin-13 (IL-13) production in ConA-induced splenocytes. In conclusion, the anti-inflammatory effects of (-)-aptosimon are attributed to the suppression of pro-inflammatory cytokines and mediators by blocking NF-κB activation. These data suggest that (-)-aptosimon as a potential therapeutic agent for inflammation-associated disorders. | - |
dc.publisher | Elsevier | - |
dc.title | Anti-inflammatory activity of (-)-aptosimon isolated from Daphne genkwa in RAW264.7 cells = 압토시몬의 항염효과 | - |
dc.title.alternative | Anti-inflammatory activity of (-)-aptosimon isolated from Daphne genkwa in RAW264.7 cells | - |
dc.type | Article | - |
dc.citation.title | International Immunopharmacology | - |
dc.citation.number | 7 | - |
dc.citation.endPage | 885 | - |
dc.citation.startPage | 878 | - |
dc.citation.volume | 9 | - |
dc.contributor.affiliatedAuthor | Ok-Kyoung Kwon | - |
dc.contributor.affiliatedAuthor | Ji Eun Yuk | - |
dc.contributor.affiliatedAuthor | Sei Ryang Oh | - |
dc.contributor.affiliatedAuthor | Hui-Seong Kim | - |
dc.contributor.affiliatedAuthor | Hyeong Kyu Lee | - |
dc.contributor.affiliatedAuthor | Kyung Seop Ahn | - |
dc.contributor.alternativeName | 이미영 | - |
dc.contributor.alternativeName | 박보영 | - |
dc.contributor.alternativeName | 권옥경 | - |
dc.contributor.alternativeName | 육지은 | - |
dc.contributor.alternativeName | 오세량 | - |
dc.contributor.alternativeName | 김희성 | - |
dc.contributor.alternativeName | 이형규 | - |
dc.contributor.alternativeName | 안경섭 | - |
dc.identifier.bibliographicCitation | International Immunopharmacology, vol. 9, no. 7, pp. 878-885 | - |
dc.identifier.doi | 10.1016/j.intimp.2009.03.012 | - |
dc.subject.keyword | (-)-aptosimon | - |
dc.subject.keyword | anti-inflammatory | - |
dc.subject.keyword | COX-2 | - |
dc.subject.keyword | IL-13 | - |
dc.subject.keyword | IL-4 | - |
dc.subject.keyword | iNOS | - |
dc.subject.local | (-)-aptosimon | - |
dc.subject.local | anti-inflammatory | - |
dc.subject.local | Anti-inflammatory | - |
dc.subject.local | COX-2 | - |
dc.subject.local | Cox-2 | - |
dc.subject.local | IL-13 | - |
dc.subject.local | IL-4 | - |
dc.subject.local | Inducible nitric oxide synthase (iNOS) | - |
dc.subject.local | Inducible nitric oxide synthase | - |
dc.subject.local | inducible nnitric oxide synthase | - |
dc.subject.local | iNOS | - |
dc.subject.local | Inducible nitric oxide synthease (iNOS) | - |
dc.subject.local | INOS | - |
dc.subject.local | inducible nitric oxide synthase | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.